Recruiting - Full Survey - Modafinil and/ or methylphenidate users without ADHD diagnosis

Approved by the moderators

Recruiting - PLEASE NOTE: if you have taken the pilot of this survey, please participate, this is the full survey Click here to take survey: Everyday attention and drug use survey I am a PhD student at London South Bank University and I am researching the use of psychoactive drugs and everyday attention. Based on the results of my first study ("Smart Drug Study"), a further study is required to understand in greater detail the off-prescription use of modafinil and methylphenidate, recreational drug use and also how people who take these drugs feel that their attention is like both on and off these drugs. If you are over 18 years of age and can spare 15-20 minutes, please complete this online survey (link found below). This survey is completely confidential and anonymous so no details that could identify you will be recorded. This study is not restricted to any country and welcomes people from all countries to participate. Even if you have no experience of taking these drugs you are still invited to participate. This survey will be open for a three month period between 6 February 2018 and 6 May 2018, after which time the survey will close. Our findings from this study will contribute to informing research on the extent of use of these drugs within the UK and internationally and will form the basis of a journal article that may be published in a peer reviewed journal. The study has been approved by the School of Applied Science Ethics Committee of London South Bank University (ref. SAS 1733). To participate, just follow this link:
Everyday attention and drug use survey


Comments


[9 Points] _PrinterPam_:

Out of curiosity, will you be mentioning (in your write-up) the limitation of not actually knowing whether participants have ADHD? The absence of a previous diagnosis doesn't preclude a person from having the disorder.

Most research of this type involves screening of potential participants and I'd hate for you to miss acknowledging this only to find out at your dissertation panel. ;)


[2 Points] rb2904:

Actually that was for OnlyInEye! I’m using an app so perhaps my error is there.


[2 Points] FixShitUp:

At the risk of being hyper literal, does recent consumption of nicotine and caffeine constitute being 'under the influence of any psychoactive drug', and make one ineligible for the survey?

Also: The options under 'Nationality' are pretty busted. You've used radio buttons for a lot of responses that are not mutually exclusive, and omitted route of administration options that are useful/necessary. Strongly recommend reviewing/revising your instrument. PM a link to a document form of the survey instrument if you'd like notes/suggestions


[1 Points] None:

[deleted]


[1 Points] rb2904:

My response to PrinterPam was this: Hi, thanks for that, I have taken this into consideration. in face this is one of my interests :-)


[1 Points] rb2904:

Thanks, it was a stipulation with ethics but I will take your advice and see what I can do about this. Thanks again!


[1 Points] Yangonin2:

/r/stims


[1 Points] arcsch:

Modafinil is not illegal in the UK FYI as you say in the debriefing. I also found that a lot of my responses of "not affected" for methylphenidate would be different from if you were asking about amfetamine - I'm assuming this may be relevant for your study considering that a lot of the questions look like ADHD screening questions and both are ADHD treatments


[0 Points] OnlyInEye:

Why are you doing a survey using two different drugs one a stimulant and the other a nootropic. One is used for narcolepsy and the other ADHD treatment. Calling one study called the Smart Drug Survey already shows you have an inherent bias. Surveys can give an inaccurate picture when not using randoming sampling your giving it to a drug subreddit. People already have an inherent bias this drug will work because they paid money. Yes it's s sunk cost but modern behavioral economics already show the effect that it can have on behavior. Also geographic location plays a huge role because of cost and alternative drug options. Your whole survey seems flawed from the start. When they do clinical trials and compare between a placebo most patients are not stuck with the cost which is a huge determinant on behavior.